You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Secukinumab for treating moderate to severe plaque psoriasis

  • Technology appraisal guidance
  • Reference number: TA350
  • Published:  22 July 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The company's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Appraisal Committee members, guideline representatives and NICE project team
  • 7 Sources of evidence considered by the Committee
  • 8 Update information

8 Update information

November 2025: We have made minor editorial changes to the wording in section 1.1 to align with the NICE guideline on psoriasis: assessment and management. This does not affect the meaning or intent of the guidance.

ISBN: 978‑1‑4731‑1334‑3


Previous page 7 Sources of evidence considered by the Committee
Back to top